The prevalence of cataract in a population with and without type 2 diabetes mellitus

Acta Ophthalmologica

Volumn 90, Issue 4, 2012, Pages 334-340

  Olafsdottir, Eydis ^a,b   Andersson, Dan K G ^c   Stefánsson, Einar ^a,b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

cataract; HbA1c; heart rate; lens opacity; metabolic control; type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD CHEMISTRY; BLOOD PRESSURE; BODY MASS; CATARACT; CONTROLLED STUDY; CORTICAL CATARACT; DIABETIC DIET; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EYE EXAMINATION; FEMALE; GLYCEMIC CONTROL; HEART RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LENS OPACITIES CLASSIFICATION SYSTEM II; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTERIOR SUBCAPSULAR CATARACT; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SWEDEN;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CATARACT; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; REGISTRIES; RISK FACTORS; SWEDEN; YOUNG ADULT;

EID: 84861638264     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2011.02326.x     Document Type: Article

References (21)

1. Arnarsson A, Jonasson F, Sasaki H, Ono M, Jonsson V, Kojima M, Katoh N, &, Sasaki K, (2002): Risk factors for nuclear lens opacification: the Reykjavik Eye Study. Dev Ophthalmol 35: 12-20.
2. Chylack LT Jr, Leske MC, McCarthy D, Khu P, Kashiwagi T, &, Sperduto R, (1989): Lens opacities classification system II (LOCS II). Arch Ophthalmol 107: 991-997.
3. Foster PJ, Wong TY, Machin D, Johnson GJ, &, Seah SK, (2003): Risk factors for nuclear, cortical and posterior subcapsular cataracts in the Chinese population of Singapore: the Tanjong Pagar Survey. Br J Ophthalmol 87: 1112-1120.
4. Hennis A, Wu SY, Nemesure B, &, Leske MC, (2004): Risk factors for incident cortical and posterior subcapsular lens opacities in the Barbados Eye Studies. Arch Ophthalmol 122: 525-530.
5. Jansson SP, Andersson DK, &, Svardsudd K, (2007): Prevalence and incidence rate of diabetes mellitus in a Swedish community during 30 years of follow-up. Diabetologia 50: 703-710.
6. Katoh N, Jonasson F, Sasaki H, Kojima M, Ono M, Takahashi N, &, Sasaki K, (2001): Cortical lens opacification in Iceland. Risk factor analysis-Reykjavik Eye Study. Acta Ophthalmol Scand 79: 154-159.
7. Klein BE, Klein R, &, Moss SE, (1985): Prevalence of cataracts in a population-based study of persons with diabetes mellitus. Ophthalmology 92: 1191-1196.
8. Klein BE, Klein R, &, Moss SE, (1995a): Incidence of cataract surgery in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Am J Ophthalmol 119: 295-300.
9. Klein BE, Klein R, Wang Q, &, Moss SE, (1995b): Older-onset diabetes and lens opacities. The Beaver Dam Eye Study. Ophthalmic Epidemiol 2: 49-55.
10. Klein BE, Klein R, &, Lee KE, (1998): Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. Am J Ophthalmol 126: 782-790.
11. Leske MC, Wu SY, Nemesure B, &, Hennis A, (2002): Risk factors for incident nuclear opacities. Ophthalmology 109: 1303-1308.
12. Pollreisz A, &, Schmidt-Erfurth U, (2010): Diabetic cataract-pathogenesis, epidemiology and treatment. J Ophthalmol 2010: 608751.
13. Rowe NG, Mitchell PG, Cumming RG, &, Wans JJ, (2000): Diabetes, fasting blood glucose and age-related cataract: the Blue Mountains Eye Study. Ophthalmic Epidemiol 7: 103-114.
14. Sasaki H, Jonasson F, Kojima M, Katoh N, Ono M, Takahashi N, &, Sasaki K, (2000): The Reykjavik Eye Study-prevalence of lens opacification with reference to identical Japanese studies. Ophthalmologica 214: 412-420.
15. Saxena S, Mitchell P, &, Rochtchina E, (2004): Five-year incidence of cataract in older persons with diabetes and pre-diabetes. Ophthalmic Epidemiol 11: 271-277.
16. Schmier JK, Halpern MT, Covert DW, &, Matthews GP, (2007): Evaluation of costs for cystoid macular edema among patients after cataract surgery. Retina 27: 621-628.
17. Stanga PE, Boyd SR, &, Hamilton AM, (1999): Ocular manifestations of diabetes mellitus. Curr Opin Ophthalmol 10: 483-489.
18. Tranos PG, Wickremasinghe SS, Stangos NT, Topouzis F, Tsinopoulos I, &, Pavesio CE, (2004): Macular edema. Surv Ophthalmol 49: 470-490.
19. Varma R, &, Torres M, (2004): Prevalence of lens opacities in Latinos: the Los Angeles Latino Eye Study. Ophthalmology 111: 1449-1456.
20. WHO Study Group (1985): Diabetes mellitus: technical report series 727. Geneva: World Health Organization.
21. Zaczek A, Olivestedt G, &, Zetterstrom C, (1999): Visual outcome after phacoemulsification and IOL implantation in diabetic patients. Br J Ophthalmol 83: 1036-1041.